Format
Sort by

Send to

Choose Destination

Selected items

Items: 11

1.

Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials.

Han SL, Wan SL.

Int J Clin Pract. 2012 Feb;66(2):199-209. doi: 10.1111/j.1742-1241.2011.02837.x. Review.

PMID:
22257045
2.
3.

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.

Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB; Treatment of Osteoporosis with Parathyroid Hormone Study Group..

Ann Intern Med. 2007 Mar 6;146(5):326-39.

PMID:
17339618
4.

Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture.

Simon JA, Recknor C, Moffett AH Jr, Adachi JD, Franek E, Lewiecki EM, McClung MR, Mautalen CA, Ragi-Eis S, Nicholson GC, Muschitz C, Nuti R, Törring O, Wang A, Libanati C.

Menopause. 2013 Feb;20(2):130-7. doi: 10.1097/gme.0b013e318267f909.

PMID:
23010883
5.

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.

Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM.

JAMA. 2001 Dec 12;286(22):2815-22.

PMID:
11735756
7.
8.

Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.

Barrett-Connor E, Wehren LE, Siris ES, Miller P, Chen YT, Abbott TA 3rd, Berger ML, Santora AC, Sherwood LM.

Menopause. 2003 Sep-Oct;10(5):412-9.

PMID:
14501602
9.

Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group.

Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Connor E, Musliner T, Thompson D.

Arthritis Rheum. 1999 Jun;42(6):1246-54.

10.
11.

The effect of different doses of calcitonin on bone mineral density and fracture risk in postmenopausal osteoporosis.

Hizmetli S, Elden H, Kaptanoglu E, Nacitarhan V, Kocagil S.

Int J Clin Pract. 1998 Oct;52(7):453-5.

PMID:
10622084
Items per page

Supplemental Content

Support Center